Skip to main content
SpringerLink
Log in

Western Perspective and Epidemiology of Gastric Cancer

  • Chapter
  • First Online:
Gastric Cancer

  • 2600 Accesses

Abstract

Gastric cancer incidence is five to tenfold higher in Eastern countries with respect to Europe and North America. Hence, Eastern surgeons got the opportunity to gain a remarkable surgical experience in high-volume series. Recently, also in the West, specialized surgical centres managed to achieve good short-term results, close to those recorded in Eastern series. However, long-term survival in Western series is still lagging behind survival recorded in Eastern series. Of note, Western patients usually present more aggressive forms, such as Helicobacter pylori negative proximal or diffuse subtypes, in particular signet ring cell (SRC). Moreover, Eastern patients are often diagnosed at an earlier stage due to mass screening programs. Hopefully, we will witness further improvements in gastric cancer management in the next years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2012. http://globocan.iarc.fr. Accessed 3 Jan 2014.

  2. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50:1330–44.

    Article  PubMed  Google Scholar 

  3. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42(2):219–40.

    Article  PubMed  Google Scholar 

  4. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol. 2006;57(suppl 3):51–65.

    Google Scholar 

  5. Henson DE, DittusC, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.

    Google Scholar 

  6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–9.

    Article  CAS  PubMed  Google Scholar 

  7. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5.

    Article  CAS  PubMed  Google Scholar 

  8. Dikken JL, Lemmens VE, Wouters MW, Wijnhoven JM, Siersema PD, Nieuwenhuijzen GA, van Sandick JW, Cats A, Verheij M, Coebergh JW, van de Velde CJ. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48:1624–32.

    Article  PubMed  Google Scholar 

  9. Dubec A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?—a SEER database analysis. J Gastrointest Surg. 2014;18:124–29.

    Google Scholar 

  10. Marrelli D, Pedrazzani C, Morgagni D, de Manzoni G, Pacelli F, Coniglio A, Marchet A, Saragoni L, Giacopuzzi S, Roviello F, Italian Research Group for Gastric Cancer (IRGGC). Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011;98:1273–83.

    Article  CAS  PubMed  Google Scholar 

  11. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol. 2002;14:107–13.

    Article  PubMed  Google Scholar 

  12. Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X, et al. Arising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18–25.

    Article  CAS  PubMed  Google Scholar 

  13. Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years’ experience at a single institute in Korea. Eur J Surg Oncol. 2008;34:36–41.

    Article  CAS  PubMed  Google Scholar 

  14. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18(7):1945–52.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Dassen AE, Dikken JL, Bosscha K, Wouters MW, Cats A, van de Velde CJ, Coebergh JW, Lemmens VE. Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol. 2014;53:138–42.

    Google Scholar 

  16. Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K, Coebergh JW. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46(6):1101–10.

    Article  CAS  PubMed  Google Scholar 

  17. Fayçal J, Bessaguet C, Nousbaum JB, Cauvin JM, Cholet F, Bideau K, Robaszkiewicz M, Gouérou H. Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol. 2005;29(1):23–32.

    Article  PubMed  Google Scholar 

  18. Bernards N, Creemers GJ, Nieuwenhuijzen GA, Bosscha K, Pruijt JF, Lemmens VE. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol. 2013;24(12):3056–60.

    Article  CAS  PubMed  Google Scholar 

  19. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg. 1993;80:1015–8.

    Article  CAS  PubMed  Google Scholar 

  20. Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, De Manzoni G. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol. 2014;20(36):12883–91.

    Google Scholar 

  21. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patients survival after D1 and D2 resections for gastric cancer: long term results of the MRC surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H. Extended lymph node dissection for gastric cancer. Dutch Gastric Cancer Group. New Engl J Med. 1999;340:908–14.

    Article  CAS  PubMed  Google Scholar 

  23. Guadagni S, Catarci M, de Manzoni G, Kinoshita T. D1 versus D2 dissection for gastric cancer. Lancet. 1995;345(8963):1517; author reply 1517–8.

    CAS  PubMed  Google Scholar 

  24. McCulloch P, Niita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach (Cochrane Review). Chichester: Wiley; 2003.

    Google Scholar 

  25. McCulloch P, Niita ME, Kazi H, Gama-Rodrigues J. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg. 2005;92:5–13.

    Article  CAS  PubMed  Google Scholar 

  26. Moenig S, Baldus S, Bollschweiler E, Ho¨lscher A. Surgery of gastric cancer—quality assurance. Viszeralchirurgie. 2005;42:42–8.

    Google Scholar 

  27. Meyer HJ, Hölscher AH, Lordick F, Messmann H, Mönig S, Schumacher C, Stahl M, Wilke H, Möhler M. Current S3 guidelines on surgical treatment of gastric carcinoma. Chirurg. 2012;83(1):31–37.

    Article  PubMed  Google Scholar 

  28. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449–72.

    Article  CAS  PubMed  Google Scholar 

  29. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A, ESMO Guidelines Working Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5) v50–v54.

    Google Scholar 

  30. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi57–63.

    Article  PubMed  Google Scholar 

  31. De Manzoni G, Baiocchi GL, Framarini M, De Giuli M, D’Ugo D, Marchet A, Nitti D, Marrelli D, Morgagni P, Rinnovati A, Rosati R, Roviello F, et al. The SIC-GIRCG 2013 consensus conference on gastric cancer. Updates Surg. 2014;66(1):1–6.

    Google Scholar 

  32. Ajani JA, Bentrem DJ, Besh S, D’Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H. Gastric Cancer, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11(5):531–46.

    Google Scholar 

  33. Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16(3):594–602.

    Article  CAS  PubMed  Google Scholar 

  34. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group Study 9501. J Clin Oncol. 2004;22:2767–73.

    Article  PubMed  Google Scholar 

  35. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Brit J Surg. 2004;91(3):283–7.

    Article  CAS  PubMed  Google Scholar 

  36. Degiuli M, Sasako M, Ponti A, Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Brit J Surg. 2010;97(5):643–9.

    Article  CAS  PubMed  Google Scholar 

  37. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.

    Article  CAS  PubMed  Google Scholar 

  38. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309–15.

    Article  CAS  PubMed  Google Scholar 

  39. Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M, Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Brit J Surg. 2014;101:23–31.

    Article  CAS  PubMed  Google Scholar 

  40. van de Velde CJH. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101:23–31.

    Article  Google Scholar 

  41. Strong VE, Yoon SS. Extended lymphadenectomy in gastric cancer is debatable. World J Surg. 2013;37:1773–7. doi:10.1007/s00268-013-2070-1 PMID:23649527.

    Article  PubMed  Google Scholar 

  42. Smith DL, Elting LS, Learn PA, Raut CP, Mansfield PF. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol. 2007;14:1846–52. doi:10.1245/s10434-007-9381-0PMID: 17406947.

    Article  PubMed  Google Scholar 

  43. Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, van de Velde CJ. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol. 2009;35(7):715–20.

    Article  CAS  PubMed  Google Scholar 

  44. Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK, Johnsen SP. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol. 2010;36(Suppl 1):S50–4.

    Article  PubMed  Google Scholar 

  45. de Steur WO, Dikken JL, Hartgrink HH. Lymph node dissection in resectable advanced gastric cancer. Dig Surg. 2013;30(2):96–103.

    Article  PubMed  Google Scholar 

  46. Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, Coupland VH, Wouters MW, Lemmens VE, van de Velde CJ, van der Geest LG, Larsson HJ, Cats A, Verheij M. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Brit J Surg. 2013;100(1):83–94.

    Article  CAS  PubMed  Google Scholar 

  47. Marrelli D, Morgagni P, de Manzoni G, Coniglio A, Marchet A, Saragoni L, Tiberio G, Roviello F, Italian Research Group for Gastric Cancer (IRGGC). Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255(3):486–91.

    Article  PubMed  Google Scholar 

  48. Ahn HS, Lee HJ, Hahn S, Kim W, Lee KU, Sano T, Edge SB, Yang HK. Evaluation of the seventh American Joint committee on cancer/international union against cancer classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010;116:5592–8.

    Article  PubMed  Google Scholar 

  49. Kikuchi S, Futawatari N, Sakuramoto S, Katada N, Yamashita K, Shibata T, Nemoto M, Watanabe M. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer. Anticancer Res. 2011;31(6):2361–5.

    PubMed  Google Scholar 

  50. Hayashi T, Yoshikawa T, Bonam K, Sue-Ling HM, Taguri M, Morita S, Tsuburaya A, Hayden JD, Grabsch HI. The Superiority of the Seventh edition of the TNM classification depends on the overall survival of the patient cohort. Comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom. Cancer. 2013;119:1330–7.

    Article  PubMed  Google Scholar 

  51. Warneke VS, Behrens HM, Hartmann JT, et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol. 2011;29:2364–71.

    Article  PubMed  Google Scholar 

  52. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;251:640–6.

    Article  PubMed  Google Scholar 

  53. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995;180:577–82.

    CAS  PubMed  Google Scholar 

  54. Pacelli F, Papa V, Caprino P, et al. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg. 2001;67:697–703.

    CAS  PubMed  Google Scholar 

  55. Talamonti MS, Kim SP, Yao KA, et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003;134:720–7.

    Article  PubMed  Google Scholar 

  56. Maeda H, Okabayashi T, Nishimori I, Sugimoto T, Namikawa T, Dabanaka K, Tsujii S, Onishi S, Kobayashi M, Hanazaki K. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206(2):306–10.

    Article  PubMed  Google Scholar 

  57. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Tomezzoli A, Pelosi G, Di Leo A, Cordiano C. Classification of lymph node metastases from carcinoma of the stomach: comparison of the old (1987) and new (1997) TNM systems. World J Surg. 1999;23(7):664–9.

    Article  PubMed  Google Scholar 

  58. Bamboat ZM, Tang LH, Vinuela E, Kuk D, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014;21:1678–85.

    Google Scholar 

  59. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah MA, Coit DG, Brennan MF. Comparison of disease-specific survival in the United States and Korea. After resection for early-stage node-negative gastric carcinoma. J Surg Oncol. 2013;107:634–40.

    Google Scholar 

  60. Theuer CP, Kurosaki T, Ziogas A, et al. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer. 2000;89:1883–92.

    Article  CAS  PubMed  Google Scholar 

  61. Al-Refaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer. 2008;113:461–9.

    Article  PubMed  Google Scholar 

  62. Marrelli D, Pedrazzani C, Corso G, et al. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg. 2009;250:43–50.

    Article  PubMed  Google Scholar 

  63. Marrelli D, De Stefano A, de Manzoni G, et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Theuer CP, Campbell BS, Peel DJ, et al. Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg. 2002;137:960–5.

    Article  PubMed  Google Scholar 

  65. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.

    Article  CAS  PubMed  Google Scholar 

  66. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715–21.

    Article  CAS  PubMed  Google Scholar 

  67. Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Jensen K, GE Adenocarcinoma Meta-analysis Group. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus (The Cochrane Collaboration. The Cochrane Library). Cochrane Database Syst Rev. 2013;5:CD008107.

    Google Scholar 

  68. Reim D, Gertler R, Novotny A, Becker K, Meyer C, Ebert M, Dobritz M, Langer R, Hoefler H, Friess H, Schumacher C. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer. Ann Surg Oncol. 2012;19:2108–18.

    Article  PubMed  Google Scholar 

  69. Messager M, Lefevre JH, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254:684–93.

    Article  PubMed  Google Scholar 

  70. Roviello F, Pedrazzani C, Marrelli D, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439–46.

    Article  CAS  PubMed  Google Scholar 

  71. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.

    Article  Google Scholar 

  72. de Manzoni G, Verlato G, Bencivenga M, Marrelli D, Di Leo A, Giacopuzzi S, Cipollari C, Roviello F. Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. Eur J Surg Oncol. 2015 Feb 4. doi: 10.1016/j.ejso.2015.01.023.

    Google Scholar 

  73. Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, Stomach Cancer Study Group of the Japan Clinical Oncology Group. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101(6):653–60.

    Article  CAS  PubMed  Google Scholar 

  74. Lamb P, Sivashanmugam T, White M, Irving M, Wayman J, Raimes S. Gastric cancer surgery—a balance of risk and radicality. Ann Roy Coll Surg. 2008;90:235–42.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Surgery and Esophagus and Stomach, Borgo Trento Hospital, University of Verona, Piazzale Stefani 1, 37138, Verona, Italy

    Dr. Giovanni de Manzoni MD

  2. Department of Medicine, Surgery and Neuroscience, Unit of Surgical Oncology, University of Siena, Policlinico Le Scotte, Siena, Italy

    Daniele Marrelli MD

  3. Surgical Oncology Presso, University of Siena, Siena, Italy

    Franco Roviello MD

  4. Public Health and Community Medicine, Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy

    Giuseppe Verlato MD, PhD

  5. Department of Surgery, Ospedale GB Morgagni, L - Pierantoni, Forli, Italy

    Paolo Morgagni MD

Authors
  1. Dr. Giovanni de Manzoni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniele Marrelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Verlato MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Morgagni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franco Roviello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni de Manzoni MD .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

de Manzoni, G., Marrelli, D., Verlato, G., Morgagni, P., Roviello, F. (2015). Western Perspective and Epidemiology of Gastric Cancer. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation